Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial

por Christoph, Annette, Eerdekens, Marie-Henriette, Kok, Maurits, Volkers, Gisela, Freynhagen, Rainer
Publicado 2017

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

por Göhler, Karin, Sokolowska, Marta, Schoedel, Kerri A., Nemeth, Robert, Kleideiter, Elke, Szeto, Isabella, Eerdekens, Marie-Henriette
Publicado 2019